Biotech13 hours ago
COLLIGO-HCM Confirms Mavacamten’s Real-World Effectiveness in Obstructive HCM
Bristol Myers Squibb’s COLLIGO-HCM real-world study shows Camzyos® (mavacamten) reduces LVOT obstruction and improves symptoms in diverse patients with obstructive hypertrophic cardiomyopathy. Results align with clinical...